GRIP Molecular Technologies

GRIP Molecular Technologies specializes in next-generation diagnostics, offering a molecular test platform for lateral flow assays that detects pathogen RNA and provides accurate results in minutes without nucleic acid amplification. Their CRISPR protease engine delivers lab-grade results at room temperature, making it adaptable for various sample... types including saliva, swabs, and urine. The technology is designed to meet the needs of point-of-need and point-of-care diagnostics, particularly for sexually transmitted infections, urinary tract infections, and upper respiratory infections. By providing fast, accurate, and affordable testing solutions, GRIP aims to close the gap in access to essential diagnostic tools in clinics and community health programs.Read More